ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Follicular Lymphoma
Leukemia

Lymphoma trials near Phoenix, AZ, USA:

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Obinutuzumab
Drug: CC-99282

Phase 1, Phase 2

Celgene
Celgene

Scottsdale, Arizona, United States and 68 other locations

with or without Sonrotoclax in participants with Mantle Cell Lymphoma (MCL).The names of the study drugs involved in this study are:* bendam...

Enrolling
Mantle Cell Lymphoma
Lymphoma
Drug: Cytarabine
Drug: Zanubrutinib

Phase 2

Christine Ryan

Phoenix, Arizona, United States and 6 other locations

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

Enrolling
T-cell Lymphoma
Cutaneous T-cell Lymphoma
Drug: Fenretinide

Phase 1

SciTech Development, Inc.

Scottsdale, Arizona, United States and 9 other locations

A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas....

Enrolling
Hodgkin Lymphoma
Lymphoma
Drug: BiCNU
Drug: VI-0609

Phase 2

Vivus

Goodyear, Arizona, United States and 3 other locations

to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...

Active, not recruiting
Lymphoma, Follicular
Drug: Golcadomide
Drug: Doxorubicin

Phase 2

Celgene
Celgene

Phoenix, Arizona, United States and 56 other locations

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...

Active, not recruiting
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

Phase 3

Loxo Oncology
Loxo Oncology

Phoenix, Arizona, United States and 194 other locations

2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in participants with R/R primary central nervous system lymphoma...

Enrolling
Refractory Primary Central Nervous System Lymphoma
Relapsed Primary Central Nervous System Lymphoma
Drug: Emavusertib
Drug: Ibrutinib

Phase 1, Phase 2

Curis

Phoenix, Arizona, United States and 42 other locations

dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as...

Active, not recruiting
Lymphoma, Non-Hodgkin's
Multiple Myeloma
Drug: Dexamethasone Oral
Drug: cemsidomide

Phase 1

C4 Therapeutics

Phoenix, Arizona, United States and 12 other locations

in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus za...

Enrolling
B Cell Lymphoma
Mantle Cell Lymphoma
Drug: Sonrotoclax
Drug: Placebo

Phase 3

BeOne Medicines

Phoenix, Arizona, United States and 150 other locations

of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Genetic: CB-010
Drug: Cyclophosphamide

Phase 1

Caribou Biosciences

Scottsdale, Arizona, United States and 37 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems